29 April 2015
SCI's London Group in partnership with the New York University in London
NYU in London
This event is no longer available for registration.
The discovery of effective anti-cancer drugs represents one of the greatest challenges to face humanity. Whilst great progress has been made in both our understanding and our ability to discover new treatments, significant challenges remain.
Dr Michael J Waring will describe the role medicinal chemistry has played in the development of today's established treatments, modern approaches to targeted therapies and future challenges in tackling resistance to these therapies. This will be showcased with stories of how some of today's recognised drugs were discovered and how modern medicinal chemistry approaches have been applied to discover new treatments, which show great promise for the future.
New York UniversityNew York University in London
SCI Comms Team
Tel: 0207 598 1594
This is a FREE event but booking is required. Places are limited so early registration is advised.
This event is now full, if you would like to be added to the waiting list, please contact email@example.com.
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Dr Michael J Waring, Principal Scientist-Medicinal Chemistry, AstraZeneca, UK